Subscribe to RSS
Please copy the URL and add it into your RSS Feed Reader.
https://www.thieme-connect.de/rss/thieme/en/10.1055-s-00000131.xml
Synfacts 2020; 16(03): 0341
DOI: 10.1055/s-0039-1691716
DOI: 10.1055/s-0039-1691716
Chemistry in Medicine and Biology
A Repurposed Chemotherapy Drug as C1 Synthon
Further Information
Publication History
Publication Date:
18 February 2020 (online)
Significance
The reagent diazomethane is employed in the formation of methyl esters, as well as for cyclopropanation reactions; however, it poses a severe risk of explosion and inhalation toxicity. In the search for alternative reagents, the authors identify the cancer chemotherapy drug temozolomide (TMZ), which is designed to methylate DNA in cancer cells.
#
Comment
TMZ is a weighable solid, non-explosive and not acutely toxic. Upon hydrolysis and release of methyl diazonium, TMZ methylates a broad range of carboxylic acids. Notably, the protecting groups THP and MOM are stable to the reaction conditions. Furthermore, catalysis with Fe(TPP)Cl enables the cyclopropanation of several styrenes.
#
#